Albania vs China: Treatment success rate for patients treated for MDR-TB
Albania
67.0%
in 2022
China
68.0%
in 2022
Albania rank
106th
China rank
104th
Treatment success rate for patients treated for MDR-TB over time
- Albania
- China
How they compare
China currently reports 68.0% against 67.0% in Albania, a difference of 1.0%.
The two have swapped places 1 time across 7 shared years of data; in 2015 it was Albania ahead.
Albania ranks 106th and China ranks 104th of 163 countries.
Across the 2 decades both report, Albania averaged higher in 1 and China in 1.
Head to head by decade
| Decade | Albania | China | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 81.2% | 50.0% | 31.2% | Albania |
| 2020s | 59.0% | 61.7% | 2.7% | China |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate for patients treated for mdr-tb, Albania or China?
- China, at 68.0% against 67.0% in Albania as of 2022.
- What is the difference in treatment success rate for patients treated for mdr-tb between Albania and China?
- 1.0%, with China ahead.
- How many years of comparable data are there for Albania and China?
- 7 years are reported by both, from 2015 to 2022.
- How do Albania and China rank globally for treatment success rate for patients treated for mdr-tb?
- Albania ranks 106th and China ranks 104th of 163 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate for patients treated for MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.